Prepared by: Dante Fichera, CPA
Announcements: Congratulations to Carole Fuller and her team at CEYX Technologies for closing their first venture round. You guys rock and have worked hard to get your company to where it is today. Keep up the good work. Also, Hamilton Apex Ventures has renamed its fund and is now operating it under the name Hamilton Bio Ventures. The partners are currently launching their second fund with a focus on life science technologies.
This reporting period companies based in California operating in the Software industry and that have raised their Series C round of financing led the pack in the amount of venture financing raised. |
 |
CapitalHunter.com was able to verify that $383 million of venture capital was invested in 33 U.S.-based companies during this week’s reporting period. The average deal size was approximately $11.61 million. The amount of venture capital invested this period increased by 38% from last periods $277 million.
During 2004, our preliminary national venture capital estimates revealed that approximately 1,450 venture financings occurred for a total of $17.5 billion. National venture activity during Q4 2004 was approximately $4.7 billion which was 2.1% over Q3 2004 and 13.91% over Q4 2003. For more information feel free to contact our offices or subscribe to our services. |
|
|
 |
Geographically, 10 California companies raised $118.05 million in venture financings. The largest private venture financing in California this period was into Visage Mobile. Visage Mobile raised $22.8 million and is a San Francisco based company that is a developer of a turnkey technology and services platform for wireless carriers and consumer brands to outsource the creation of mobile virtual network operators. |
|
|
 |
The software sector raised 34% of the venture capital this period. Thirteen software companies raised $130.05 million in venture financing. The largest private venture financing in the software sector this period was into Visage Mobile. |
|
|
 |
Companies raising their Series C round of financing led this week’s venture capital activity. Series C financings represented 33% of the total venture capital deployed this period. The largest Series C financing shared by both Infinity Pharmaceuticals and Revivio. Both companies raised $25 million. |
|
|
 |
|
The three largest venture deals this period are as follows: |
| |
Company |
Industry |
Investment |
| 1 |
Infinity Pharmaceuticals |
Biotechnology |
$25 million |
| 2 |
Presidion Solutions |
Business Services |
$25 million |
| 3 |
Revivio |
Network & Equipment |
$25 million |
|
 |
|
The following nine and other unnamed investors funded the above mentioned top three venture capital investments for $75 Million: |
| 1 | Bessemer Venture Partners | | 2 | Charles River Ventures | | 3 | Eastward Capital Partners | | 4 | Flagship Ventures | | 5 | Globespan Capital Partners | | 6 | Johnson and Johnson Development Corp. | | 7 | Mirabilis Ventures | | 8 | Nomura Securities International | | 9 | Novartis |
|
A total of 64 equity financings of private and public companies occurred during this reporting period. Each of the 64 equity financings are profiled in a weekly report which include venture financings, private placements, secondary offerings, PIPE’s, and IPO’s.
About CapitalHunter.com
CapitalHunter.com is a web-based financial information company that identifies, preserves and electronically disseminates worldwide data on venture capital and other equity financings. Customers utilize the CapitalHunter.com searchable database to research newly and historic financings and to identify active investors.
Please visit www.capitalhunter.com and get immediate access. New subscribers can request a free investor analysis. |
|
|
|
©2003 Capital Hunter, Inc. all rights reserved
|
To be REMOVED from this free service, CLICK HERE |
